2024 HCPCS Code C9168
Injection, mirikizumab-mrkz, 1 mg
| Notice | HCPCS C9168 terminated on June 30, 2024. |
| Short Description | Injection, mirikizumab-mrkz |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Action Code | D - Discontinue procedure or modifier code |
| HCPCS Action Effective Date | July 01, 2024 |
| HCPCS Code Added Date | April 01, 2024 |
| HCPCS Pricing Indicator Code | 53 - Statute |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C9140 - Afstyla factor viii recomb
- C9141 - Factor viii pegylated-aucl
- C9142 - Inj, alymsys, 10 mg
- C9143 - Cocaine hcl nasal (numbrino)
- C9144 - Inj, bupivacaine (posimir)
- C9145 - Inj, aponvie, 1 mg
- C9146 - Inj, elahere, 1 mg
- C9147 - Inj, tremelimumab-actl, 1 mg
- C9148 - Inj, teclistamab-cqyv, 0.5mg
- C9149 - Inj, teplizumab-mzwv, 5 mcg
- C9150 - Xe129 xenon, diagnostic
- C9151 - Inj, pegcetacoplan 1 mg
- C9152 - Inj, abilify asimtufii, 1 mg
- C9153 - Inj, amisulpride, 1 mg
- C9154 - Inj buprenorph (brixadi) 1mg
- C9155 - Inj epcoritamab-bysp,0.16 mg
- C9156 - Flotufolastat f18, dia 1 mci
- C9157 - Inj, tofersen, 1 mg
- C9158 - Inj, uzedy, 1 mg
- C9159 - Inj, balfaxar, per i.u